In addition to the benefits of insulin for diabetes treatment, it is suggested that regular monitoring of insulin levels and screening and treatment for subclinical insulinemia may be an efficient colorectal and endometrial cancer prevention strategy. The gene discussed is INS; the disease is diabetes mellitus.